PD-L1 testing in advance stage lung cancer using cytology samples: suitability and interobserver agreement. How well are we doing?

被引：0
|
作者：
Elshiekh, M. [1 ]
Iles, S. [1 ]
Hopcroft, D. [1 ]
Trivedi, P. [1 ]
Gupta, N. [1 ]
Bhagwat, P. [1 ]
Viola, P. [1 ]
机构：
[1] Imperial Coll NHS Trust, Cellular Dept, Hammersmith Hosp, London, England
来源：
LUNG CANCER | 2019年 / 127卷
关键词：
D O I：
10.1016/S0169-5002(19)30094-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
50
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 38 条
  • [21] Cost-Effectiveness of PD-L1 Testing for Guiding Immunotherapy in Non-Small Cell Lung Cancer (Stage IIA-IIIB & Stage IV) Patients in China
    Li, Y.
    Chen, Y.
    Ming, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S721 - S721
  • [22] Assessment of Clinical Outcomes of PD-L1 Testing of Non-Small Cell Lung Carcinoma Using Cytology Cellblock Specimens: An Experience of a Large Tertiary Care Institution
    Alhamar, Mohamed
    Arora, Kanika
    Oyedeji, Oluwayomi
    Zhang, Ziying
    Schultz, Daniel
    Stone, Chad
    Perry, Kyle
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 191 - 192
  • [23] Assessment of Clinical Outcomes of PD-L1 Testing of Non-Small Cell Lung Carcinoma Using Cytology Cellblock Specimens: An Experience of a Large Tertiary Care Institution
    Alhamar, Mohamed
    Arora, Kanika
    Oyedeji, Oluwayomi
    Zhang, Ziying
    Schultz, Daniel
    Stone, Chad
    Perry, Kyle
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 191 - 192
  • [24] PD-L1 testing of non-small cell lung cancer using different antibodies and platforms: a Swiss cross-validation study
    Spasenija Savic
    Sabina Berezowska
    Serenella Eppenberger-Castori
    Gieri Cathomas
    Joachim Diebold
    Achim Fleischmann
    Wolfram Jochum
    Paul Komminoth
    Thomas McKee
    Igor Letovanec
    Zerina Jasarevic
    Matthias Rössle
    Gad Singer
    Michael von Gunten
    Andreas Zettl
    Roland Zweifel
    Alex Soltermann
    Lukas Bubendorf
    Virchows Archiv, 2019, 475 : 67 - 76
  • [25] PD-L1 testing of non-small cell lung cancer using different antibodies and platforms: a Swiss cross-validation study
    Savic, Spasenija
    Berezowska, Sabina
    Eppenberger-Castori, Serenella
    Cathomas, Gieri
    Diebold, Joachim
    Fleischmann, Achim
    Jochum, Wolfram
    Komminoth, Paul
    McKee, Thomas
    Letovanec, Igor
    Jasarevic, Zerina
    Roessle, Matthias
    Singer, Gad
    von Gunten, Michael
    Zettl, Andreas
    Zweifel, Roland
    Soltermann, Alex
    Bubendorf, Lukas
    VIRCHOWS ARCHIV, 2019, 475 (01) : 67 - 76
  • [26] Predicting PD-L1 expression using [18F]FDG PET/CT in early stage non-small cell lung cancer (NSCLC)
    Hughes, D. J.
    Josephides, E.
    O'Shea, R.
    Manickavasagar, T.
    Horst, C.
    Hunter, S.
    Taniere, P.
    Nonaka, D.
    Spicer, J.
    Goh, V.
    Bille, A.
    Karapanagiotou, E. M.
    Cook, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S741 - S741
  • [27] Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
    Ilie, Marius
    Ngo-Mai, Melanie
    Long-Mira, Elodie
    Lassalle, Sandra
    Butori, Catherine
    Bence, Coraline
    Hamila, Marame
    Hofman, Veronique
    Hofman, Paul
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (139):
  • [28] Optimized protocols to determine PD-L1 expression on tumor tissue and cytology samples from non-small cell lung cancer (NSCLC) patients using the 22C3 antibody with various immunohistochemistry (IHC) autostainers
    Ilie, M.
    Khambata-Ford, S.
    Copie-Bergman, C.
    Huang, L.
    Mogg, R.
    Juco, J.
    Hofman, V.
    Hofman, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [29] Predicting Clinical Outcomes of Patients with Stage III Non-Small-Cell Lung Cancer Treated with Concurrent Chemoradiation with and without PD-1/PD-L1 Inhibitors Using Cone Beam Computed Tomography
    Almeldin, D. S.
    Kim, S.
    Khan, A.
    Vergalasova, I.
    Nie, K.
    Patel, M.
    Aisner, J.
    Malhotra, J.
    Jabbour, S. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E122 - E123
  • [30] Therapy selection and monitoring of early and late stage non small cell lung cancer (NSCLC) using a novel circulating tumor cells (CTCs) PD-L1 blood test.
    Chen, Yen-Lin
    Huang, Wen-Jie
    Patterson, Bruce Kendrick
    Chargin, Amanda
    Hsieh, Chia-Hsin
    Hsieh, Ruey Kuen
    Amin, Mahul
    Segurado, Oscar
    Shao, Hung-Jen
    Lin, Feng-Ming
    Chang, Shih-En
    Wu, Jen-chia
    Lai, Jr-Ming
    Hsieh, Ben
    Javey, Mana
    Mei, Rui
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
1234